Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia
- PMID: 26228018
- PMCID: PMC4822533
- DOI: 10.1016/j.jri.2015.07.004
Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia
Abstract
The human placenta is a multifunctional organ that grows and adapts to increasing fetal demand and fluctuations in the intrauterine environment. It is subjected to physiological and pathological changes in local oxygenation, both of which induce adaptive changes. In early pregnancy a low PO2 is the normal physiological state and this is not hypoxic-there is no perturbation of ATP/ADP ratios and, if the placenta is sampled very rapidly, little HIF1α is detected in human first-trimester placental villi. Nonetheless, HIF1α can be increased and activated by culture. However, the placenta does show evidence of stress under pathological conditions. For example, in cases of pre-eclampsia where delivery by caesarean section is necessitated for maternal well-being before 34 weeks' gestation, placental endoplasmic reticulum stress is evident. Cases delivered ≥34 weeks are indistinguishable from normal term controls. One consequence of placental stress, whether oxidative, related to the endoplasmic reticulum or immunological, is that factors are released into the maternal circulation, which affects the endothelium, leading to the maternal syndrome. Soluble FLT1 may contribute directly to this and the most likely mechanism is direct action on the maternal endothelium. sFLT1 is able to form a heterodimer with cell surface VEGF receptors and is therefore able to have a dominant negative effect (in addition to acting as a competitive inhibitor by simply binding vascular endothelial growth factor A [VEGFA] and placental growth factor [PlGF]). This leads in vitro to the sensitisation of endothelial cells to low levels of TNFα.
Keywords: ER stress; Hypoxia; Pre-eclampsia; Unfolded protein response; sFLT1.
Copyright © 2015 Z. Published by Elsevier Ireland Ltd.. All rights reserved.
Figures
![Fig. 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7427/4822533/da575f0e6115/gr1.gif)
![Fig. 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7427/4822533/a0bde0370ce1/gr2.gif)
![Fig. 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7427/4822533/38a2b0363590/gr3.gif)
Similar articles
-
Inflammation-induced fetal growth restriction in rats is associated with increased placental HIF-1α accumulation.PLoS One. 2017 Apr 19;12(4):e0175805. doi: 10.1371/journal.pone.0175805. eCollection 2017. PLoS One. 2017. PMID: 28423052 Free PMC article.
-
Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.Hum Reprod. 2008 Jun;23(6):1407-15. doi: 10.1093/humrep/den114. Epub 2008 Apr 14. Hum Reprod. 2008. PMID: 18413304
-
Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?Am J Obstet Gynecol. 2008 Apr;198(4):428.e1-6. doi: 10.1016/j.ajog.2007.10.783. Epub 2008 Jan 14. Am J Obstet Gynecol. 2008. PMID: 18191808
-
Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.J Reprod Immunol. 2009 Nov;82(2):106-11. doi: 10.1016/j.jri.2009.09.001. Epub 2009 Oct 23. J Reprod Immunol. 2009. PMID: 19853925 Review.
-
Inflammation and pre-eclampsia.Semin Fetal Neonatal Med. 2006 Oct;11(5):309-16. doi: 10.1016/j.siny.2006.04.001. Epub 2006 Jul 7. Semin Fetal Neonatal Med. 2006. PMID: 16828580 Review.
Cited by
-
Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.Am J Physiol Heart Circ Physiol. 2020 Sep 1;319(3):H661-H681. doi: 10.1152/ajpheart.00202.2020. Epub 2020 Aug 7. Am J Physiol Heart Circ Physiol. 2020. PMID: 32762557 Free PMC article. Review.
-
Paternal obesity induces placental hypoxia and sex-specific impairments in placental vascularization and offspring metabolism†.Biol Reprod. 2022 Aug 9;107(2):574-589. doi: 10.1093/biolre/ioac066. Biol Reprod. 2022. PMID: 35377412 Free PMC article.
-
Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia.Microcirculation. 2018 Oct 19:e12508. doi: 10.1111/micc.12508. Online ahead of print. Microcirculation. 2018. PMID: 30338879 Free PMC article.
-
Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia.Int J Mol Sci. 2023 Apr 4;24(7):6744. doi: 10.3390/ijms24076744. Int J Mol Sci. 2023. PMID: 37047717 Free PMC article. Review.
-
Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.Adv Pharmacol. 2016;77:361-431. doi: 10.1016/bs.apha.2016.04.008. Epub 2016 Jun 14. Adv Pharmacol. 2016. PMID: 27451103 Free PMC article.
References
-
- Barleon B., Totzke F., Herzog C., Blanke S., Kremmer E., Siemeister G., Marmé D., Martiny-Baron G. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J. Biol. Chem. 1997;272:10382–10388. - PubMed
-
- Benton S.J., Hu Y., Xie F., Kupfer K., Lee S.-W., Magee L.A., Dadelszen von P. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. Am. J. Obstet. Gynecol. 2011;205(469):e1–e8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources